(1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate

C73H90N10O10 — CID 167576845

IUPAC(1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate
SMILESCC(=O)c1nn2c3c(cc(N)cc13)CCCCCCC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(C)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(NC(=O)OC(C)(C)C)cc13)CCCCCCC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(C)ccc4C)N(C(=O)C2)[C@@H]1C3
InChIInChI=1S/C39H49N5O6.C34H41N5O4/c1-23-13-14-24(2)40-30(23)19-32(47)31-20-39-16-15-28(46)12-10-8-7-9-11-26-17-27(41-37(49)50-38(4,5)6)18-29-35(25(3)45)42-43(36(26)29)22-34(48)44(31)33(39)21-39;1-20-10-11-21(2)36-27(20)16-29(42)28-17-34-13-12-25(41)9-7-5-4-6-8-23-14-24(35)15-26-32(22(3)40)37-38(33(23)26)19-31(43)39(28)30(34)18-34/h13-14,17-18,31,33H,7-12,15-16,19-22H2,1-6H3,(H,41,49);10-11,14-15,28,30H,4-9,12-13,16-19,35H2,1-3H3/t31-,33+,39-;28-,30+,34-/m00/s1
InChIKeyGQNKYCQCJNDXFJ-NQCVVZOTSA-N
MW1267.58 g/mol
LogP11.49
Rot. Bonds9

About (1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate

(1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate (PubChem CID 167576845) has the molecular formula C73H90N10O10 and a molecular weight of 1267.58 g/mol. Its IUPAC name is (1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate.

Molecular Properties

Compound Name(1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate
PubChem CID167576845
Molecular FormulaC73H90N10O10
Molecular Weight1267.58 g/mol
Exact Mass1266.68
IUPAC Name(1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate
SMILESCC(=O)c1nn2c3c(cc(N)cc13)CCCCCCC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(C)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(NC(=O)OC(C)(C)C)cc13)CCCCCCC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(C)ccc4C)N(C(=O)C2)[C@@H]1C3
InChIInChI=1S/C39H49N5O6.C34H41N5O4/c1-23-13-14-24(2)40-30(23)19-32(47)31-20-39-16-15-28(46)12-10-8-7-9-11-26-17-27(41-37(49)50-38(4,5)6)18-29-35(25(3)45)42-43(36(26)29)22-34(48)44(31)33(39)21-39;1-20-10-11-21(2)36-27(20)16-29(42)28-17-34-13-12-25(41)9-7-5-4-6-8-23-14-24(35)15-26-32(22(3)40)37-38(33(23)26)19-31(43)39(28)30(34)18-34/h13-14,17-18,31,33H,7-12,15-16,19-22H2,1-6H3,(H,41,49);10-11,14-15,28,30H,4-9,12-13,16-19,35H2,1-3H3/t31-,33+,39-;28-,30+,34-/m00/s1
InChIKeyGQNKYCQCJNDXFJ-NQCVVZOTSA-N
XLogP11.49
TPSA268.81 Ų
H-Bond Donors2
H-Bond Acceptors17
Rotatable Bonds9
Heavy Atoms93
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001267.58
LogP ≤ 511.49
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aniline', 'substructure': 'N/A'}

Analyze (1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate?
The IUPAC name of (1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate (CID 167576845) is (1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate.
What is the SMILES notation for (1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate?
The canonical SMILES for (1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate is CC(=O)c1nn2c3c(cc(N)cc13)CCCCCCC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(C)ccc4C)N(C(=O)C2)[C@@H]1C3.CC(=O)c1nn2c3c(cc(NC(=O)OC(C)(C)C)cc13)CCCCCCC(=O)CC[C@@]13C[C@@H](C(=O)Cc4nc(C)ccc4C)N(C(=O)C2)[C@@H]1C3.
What is the InChIKey of (1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate?
The InChIKey is GQNKYCQCJNDXFJ-NQCVVZOTSA-N. The full InChI is InChI=1S/C39H49N5O6.C34H41N5O4/c1-23-13-14-24(2)40-30(23)19-32(47)31-20-39-16-15-28(46)12-10-8-7-9-11-26-17-27(41-37(49)50-38(4,5)6)18-29-35(25(3)45)42-43(36(26)29)22-34(48)44(31)33(39)21-39;1-20-10-11-21(2)36-27(20)16-29(42)28-17-34-13-12-25(41)9-7-5-4-6-8-23-14-24(35)15-26-32(22(3)40)37-38(33(23)26)19-31(43)39(28)30(34)18-34/h13-14,17-18,31,33H,7-12,15-16,19-22H2,1-6H3,(H,41,49);10-11,14-15,28,30H,4-9,12-13,16-19,35H2,1-3H3/t31-,33+,39-;28-,30+,34-/m00/s1.
What are the key properties of (1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate?
(1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate has a molecular weight of 1267.58 g/mol, XLogP of 11.49, 9 rotatable bonds, 2 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,22R,25S)-16-acetyl-13-amino-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraene-4,20-dione;tert-butyl N-[(1R,22R,25S)-16-acetyl-25-[2-(3,6-dimethyl-2-pyridinyl)acetyl]-4,20-dioxo-17,18,21-triazapentacyclo[19.2.2.111,15.01,22.018,26]hexacosa-11(26),12,14,16-tetraen-13-yl]carbamate is sourced from PubChem (CID 167576845), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).